Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:15:27 UTC |
---|
HMDB ID | HMDB0001123 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 2-Aminobenzoic acid |
---|
Description | 2-Aminobenzoic acid, also known as anthranilic acid or O-aminobenzoate, belongs to the class of organic compounds known as aminobenzoic acids. These are benzoic acids containing an amine group attached to the benzene moiety. Within humans, 2-aminobenzoic acid participates in a number of enzymatic reactions. In particular, 2-aminobenzoic acid and formic acid can be biosynthesized from formylanthranilic acid through its interaction with the enzyme kynurenine formamidase. In addition, 2-aminobenzoic acid and L-alanine can be biosynthesized from L-kynurenine through its interaction with the enzyme kynureninase. It is a substrate of enzyme 2-Aminobenzoic acid hydroxylase in benzoate degradation via hydroxylation pathway (KEGG). In humans, 2-aminobenzoic acid is involved in tryptophan metabolism. Outside of the human body, 2-Aminobenzoic acid has been detected, but not quantified in several different foods, such as mamey sapotes, prairie turnips, rowals, natal plums, and hyacinth beans. This could make 2-aminobenzoic acid a potential biomarker for the consumption of these foods. 2-Aminobenzoic acid is a is a tryptophan-derived uremic toxin with multidirectional properties that can affect the hemostatic system. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. Chronic exposure of uremic toxins can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. |
---|
Structure | InChI=1S/C7H7NO2/c8-6-4-2-1-3-5(6)7(9)10/h1-4H,8H2,(H,9,10) |
---|
Synonyms | Value | Source |
---|
2-Aminobenzoesaeure | ChEBI | 2-Carboxyaniline | ChEBI | O-Aminobenzoesaeure | ChEBI | O-Aminobenzoic acid | ChEBI | O-Carboxyaniline | ChEBI | Vitamin L1 | ChEBI | Anthranilic acid | Kegg | 2-Aminobenzoate | Kegg | O-Aminobenzoate | Generator | Anthranilate | Generator | Anthranilic acid, cadmium salt | HMDB | Anthranilic acid, calcium (2:1) salt | HMDB | Anthranilic acid, monolithium salt | HMDB | Sodium anthranilate | HMDB | Anthranilic acid, dihydrochloride | HMDB | Anthranilic acid, hydrochloride | HMDB | Anthranilic acid, monosodium salt | HMDB | 1-Amino-2-carboxybenzene | HMDB | 2-Amino-benzoate | HMDB | 2-Amino-benzoic acid | HMDB | 2-Aminophenylacetate | HMDB | 2-Aminophenylacetic acid | HMDB | Anthranate | HMDB | Anthranic acid | HMDB | Anthranilic acid GR | HMDB | Carboxyaniline | HMDB | H-2-Abz-OH | HMDB | Kyselina anthranilova | HMDB | Kyselina O-aminobenzoova | HMDB | O-Amino-benzoate | HMDB | O-Amino-benzoic acid | HMDB | O-Anthranilate | HMDB | O-Anthranilic acid | HMDB | Ortho-amidobenzoate | HMDB | Ortho-amidobenzoic acid | HMDB | Ortho-aminobenzoate | HMDB | Ortho-aminobenzoic acid | HMDB | Vitamin L | HMDB |
|
---|
Chemical Formula | C7H7NO2 |
---|
Average Molecular Weight | 137.136 |
---|
Monoisotopic Molecular Weight | 137.047678473 |
---|
IUPAC Name | 2-aminobenzoic acid |
---|
Traditional Name | 2-aminobenzoic acid |
---|
CAS Registry Number | 118-92-3 |
---|
SMILES | NC1=CC=CC=C1C(O)=O |
---|
InChI Identifier | InChI=1S/C7H7NO2/c8-6-4-2-1-3-5(6)7(9)10/h1-4H,8H2,(H,9,10) |
---|
InChI Key | RWZYAGGXGHYGMB-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as aminobenzoic acids. These are benzoic acids containing an amine group attached to the benzene moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Benzoic acids and derivatives |
---|
Direct Parent | Aminobenzoic acids |
---|
Alternative Parents | |
---|
Substituents | - Aminobenzoic acid
- Benzoic acid
- Benzoyl
- Aniline or substituted anilines
- Vinylogous amide
- Amino acid or derivatives
- Amino acid
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxide
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Amine
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 146.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 3.5 mg/mL | Not Available | LogP | 1.21 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
2-Aminobenzoic acid,1TMS,isomer #1 | C[Si](C)(C)OC(=O)C1=CC=CC=C1N | 1498.0 | Semi standard non polar | 33892256 | 2-Aminobenzoic acid,1TMS,isomer #2 | C[Si](C)(C)NC1=CC=CC=C1C(=O)O | 1607.4 | Semi standard non polar | 33892256 | 2-Aminobenzoic acid,2TMS,isomer #1 | C[Si](C)(C)NC1=CC=CC=C1C(=O)O[Si](C)(C)C | 1600.8 | Semi standard non polar | 33892256 | 2-Aminobenzoic acid,2TMS,isomer #1 | C[Si](C)(C)NC1=CC=CC=C1C(=O)O[Si](C)(C)C | 1634.8 | Standard non polar | 33892256 | 2-Aminobenzoic acid,2TMS,isomer #1 | C[Si](C)(C)NC1=CC=CC=C1C(=O)O[Si](C)(C)C | 1778.7 | Standard polar | 33892256 | 2-Aminobenzoic acid,2TMS,isomer #2 | C[Si](C)(C)N(C1=CC=CC=C1C(=O)O)[Si](C)(C)C | 1660.6 | Semi standard non polar | 33892256 | 2-Aminobenzoic acid,2TMS,isomer #2 | C[Si](C)(C)N(C1=CC=CC=C1C(=O)O)[Si](C)(C)C | 1772.2 | Standard non polar | 33892256 | 2-Aminobenzoic acid,2TMS,isomer #2 | C[Si](C)(C)N(C1=CC=CC=C1C(=O)O)[Si](C)(C)C | 1839.3 | Standard polar | 33892256 | 2-Aminobenzoic acid,3TMS,isomer #1 | C[Si](C)(C)OC(=O)C1=CC=CC=C1N([Si](C)(C)C)[Si](C)(C)C | 1633.8 | Semi standard non polar | 33892256 | 2-Aminobenzoic acid,3TMS,isomer #1 | C[Si](C)(C)OC(=O)C1=CC=CC=C1N([Si](C)(C)C)[Si](C)(C)C | 1731.4 | Standard non polar | 33892256 | 2-Aminobenzoic acid,3TMS,isomer #1 | C[Si](C)(C)OC(=O)C1=CC=CC=C1N([Si](C)(C)C)[Si](C)(C)C | 1712.5 | Standard polar | 33892256 | 2-Aminobenzoic acid,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C1=CC=CC=C1N | 1747.5 | Semi standard non polar | 33892256 | 2-Aminobenzoic acid,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=CC=CC=C1C(=O)O | 1858.5 | Semi standard non polar | 33892256 | 2-Aminobenzoic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=CC=CC=C1C(=O)O[Si](C)(C)C(C)(C)C | 2045.2 | Semi standard non polar | 33892256 | 2-Aminobenzoic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=CC=CC=C1C(=O)O[Si](C)(C)C(C)(C)C | 2031.4 | Standard non polar | 33892256 | 2-Aminobenzoic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=CC=CC=C1C(=O)O[Si](C)(C)C(C)(C)C | 2087.6 | Standard polar | 33892256 | 2-Aminobenzoic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C1=CC=CC=C1C(=O)O)[Si](C)(C)C(C)(C)C | 2085.5 | Semi standard non polar | 33892256 | 2-Aminobenzoic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C1=CC=CC=C1C(=O)O)[Si](C)(C)C(C)(C)C | 2140.7 | Standard non polar | 33892256 | 2-Aminobenzoic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C1=CC=CC=C1C(=O)O)[Si](C)(C)C(C)(C)C | 2058.6 | Standard polar | 33892256 | 2-Aminobenzoic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C1=CC=CC=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2278.8 | Semi standard non polar | 33892256 | 2-Aminobenzoic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C1=CC=CC=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2301.9 | Standard non polar | 33892256 | 2-Aminobenzoic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C1=CC=CC=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2116.6 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - 2-Aminobenzoic acid GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-014i-1950000000-5595652a2e8f93679437 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 2-Aminobenzoic acid GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-014i-1960000000-889ed538406d5aa57a5d | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 2-Aminobenzoic acid GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-00xr-9650000000-e0611721f0bf7b5bb2f8 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 2-Aminobenzoic acid GC-MS (1 TMS) | splash10-00r6-2910000000-0daf33fe6231b5e15b0e | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 2-Aminobenzoic acid GC-MS (2 TMS) | splash10-014i-3970000000-3351c7d8036c42c4cd41 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 2-Aminobenzoic acid EI-B (Non-derivatized) | splash10-00kf-9400000000-b65ee27505e8c4bcca28 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 2-Aminobenzoic acid EI-B (Non-derivatized) | splash10-014i-0490000000-4165d1d7b8fff53889dd | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 2-Aminobenzoic acid GC-EI-TOF (Non-derivatized) | splash10-014i-1950000000-5595652a2e8f93679437 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 2-Aminobenzoic acid GC-EI-TOF (Non-derivatized) | splash10-014i-1960000000-889ed538406d5aa57a5d | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 2-Aminobenzoic acid GC-EI-TOF (Non-derivatized) | splash10-00xr-9650000000-e0611721f0bf7b5bb2f8 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 2-Aminobenzoic acid GC-MS (Non-derivatized) | splash10-00r6-2910000000-0daf33fe6231b5e15b0e | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 2-Aminobenzoic acid GC-MS (Non-derivatized) | splash10-014i-3970000000-3351c7d8036c42c4cd41 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 2-Aminobenzoic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-00kr-7900000000-a9c510a71b30a8fcc1b8 | 2016-09-22 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 2-Aminobenzoic acid GC-MS (1 TMS) - 70eV, Positive | splash10-00di-7900000000-cb7be965685a5ee30fbd | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 2-Aminobenzoic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 2-Aminobenzoic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-014u-9600000000-5b8e271f29d04a87c89a | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid EI-B (HITACHI RMU-7M) , Positive-QTOF | splash10-00kf-9400000000-395d42e11895b80f4e9c | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-000i-0900000000-8c390367e035aea8527a | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-0006-9000000000-899b596a227cd9a1769d | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-014i-0900000000-3cc9be013399e30d7eae | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-00di-0900000000-655ef8fc722e0b1b6d14 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-000i-0900000000-4d0520217d12a10f9273 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-0006-9000000000-bab8539624c8af4e6434 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-014i-0900000000-f51f2db6bf1da2e26d20 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-00di-0900000000-86d698a8c81a3e765840 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-000i-0900000000-6df94712ad580bebfd21 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-0006-9100000000-a1ce64280c2d7f3b85df | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-0006-9000000000-454f848122c778e951ad | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative-QTOF | splash10-0006-9000000000-7de473c1ca6bf702b2ac | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative-QTOF | splash10-0006-9000000000-94f19baa1ae36f43be60 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-00di-2900000000-c2bbbe5e00434e635ad2 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-00di-4900000000-f8f84a5536375300afbd | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-00r6-9200000000-fccd86d3a0a4bfe2e5d7 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-014i-9000000000-91ceb340e5cf91473cba | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-014i-9000000000-80972c552b97ae764bc4 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Positive-QTOF | splash10-00di-4900000000-f494672ce9de4818b8c5 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2-Aminobenzoic acid LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Negative-QTOF | splash10-0006-9300000000-9bbb2f00817538e072d5 | 2012-08-31 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Aminobenzoic acid 10V, Positive-QTOF | splash10-0079-0900000000-e7e07e78dd5baa5c3f87 | 2015-05-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Aminobenzoic acid 20V, Positive-QTOF | splash10-00di-1900000000-54a3d793d6fbf0220b47 | 2015-05-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Aminobenzoic acid 40V, Positive-QTOF | splash10-0umi-9200000000-bd780d6ca957af006488 | 2015-05-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2-Aminobenzoic acid 10V, Negative-QTOF | splash10-000f-9800000000-93111d593c96a3298a6c | 2015-05-27 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Experimental 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | 2021-10-10 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
General References | - Igari T, Tsuchizawa M, Shimamura T: Alteration of tryptophan metabolism in the synovial fluid of patients with rheumatoid arthritis and osteoarthritis. Tohoku J Exp Med. 1987 Oct;153(2):79-86. [PubMed:3500530 ]
- Calandra P: Research on tryptophan metabolites "via kynurenine" in epidermis of man and mouse. Acta Vitaminol Enzymol. 1975;29(1-6):158-60. [PubMed:1244085 ]
- Di Marco GS, Quinto BM, Juliano M, Carmona AK, Stella RC, Plavnik FL, Casarini DE: Purification and characterization of a neutral endopeptidase-like enzyme from human urine. J Hypertens. 1998 Dec;16(12 Pt 2):1971-8. [PubMed:9886885 ]
- Hagag N, Birnbaum ER, Darnall DW: Resonance energy transfer between cysteine-34, tryptophan-214, and tyrosine-411 of human serum albumin. Biochemistry. 1983 May 10;22(10):2420-7. [PubMed:6860638 ]
- Little CH, Georgiou GM, Shelton MJ, Simpson F, Cone RE: Clinical and immunological responses in subjects sensitive to solvents. Arch Environ Health. 1999 Jan-Feb;54(1):6-14. [PubMed:10025410 ]
- Ritchie MR, Morton MS, Thompson AM, Deighton N, Blake A, Cummings JH, Steel CM: Investigation of the reliability of 24 h urine excretion as a biomarker of isoflavone exposure over time and over a wide range of isoflavone intakes. Eur J Clin Nutr. 2004 Sep;58(9):1286-9. [PubMed:15054404 ]
- Ortega RM, Andres P, Martinez RM, Lopez-Sobaler AM: Vitamin A status during the third trimester of pregnancy in Spanish women: influence on concentrations of vitamin A in breast milk. Am J Clin Nutr. 1997 Sep;66(3):564-8. [PubMed:9280174 ]
- Alves MF, Araujo MC, Juliano MA, Oliveira EM, Krieger JE, Casarini DE, Juliano L, Carmona AK: A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity. Braz J Med Biol Res. 2005 Jun;38(6):861-8. Epub 2005 Jun 1. [PubMed:15933779 ]
- Soma J, Sugawara T, Huang YD, Nakajima J, Kawamura M: Tranilast slows the progression of advanced diabetic nephropathy. Nephron. 2002;92(3):693-8. [PubMed:12372957 ]
- Ahmad S: The functional roles of cytochrome P-450 mediated systems: present knowledge and future areas of investigations. Drug Metab Rev. 1979;10(1):1-14. [PubMed:118858 ]
- Spivak W, Carey MC: Reverse-phase h.p.l.c. separation, quantification and preparation of bilirubin and its conjugates from native bile. Quantitative analysis of the intact tetrapyrroles based on h.p.l.c. of their ethyl anthranilate azo derivatives. Biochem J. 1985 Feb 1;225(3):787-805. [PubMed:3919713 ]
- Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A: Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012 Jul;23(7):1258-70. doi: 10.1681/ASN.2011121175. Epub 2012 May 24. [PubMed:22626821 ]
|
---|